$0.49
2.71% day before yesterday
Nasdaq, Aug 22, 10:00 pm CET

Harvard Bioscience, Inc. Stock price

$0.49
+0.05 10.38% 1M
-0.44 47.45% 6M
-1.62 76.82% YTD
-2.35 82.78% 1Y
-2.68 84.57% 3Y
-3.04 86.15% 5Y
-3.85 88.73% 10Y
-1.84 79.05% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.01 2.71%

Key metrics

Basic
Market capitalization
$21.8m
Enterprise Value
$49.2m
Net debt
$27.4m
Cash
$7.4m
Shares outstanding
44.5m
Valuation (TTM | estimate)
P/E
negative | 9.6
P/S
0.2 | 0.2
EV/Sales
0.6 | 0.6
EV/FCF
11.9
P/B
1.4
Financial Health
Equity Ratio
50.0%
Return on Equity
-19.6%
ROCE
-15.6%
ROIC
-6.2%
Debt/Equity
2.2
Financials (TTM | estimate)
Revenue
$88.8m | $88.9m
EBITDA
$1.0m | $7.4m
EBIT
$-3.9m | $-25.7m
Net Income
$-57.4m | $2.3m
Free Cash Flow
$4.1m
Growth (TTM | estimate)
Revenue
-12.2% | -5.6%
EBITDA
27.2% | 6,262.5%
EBIT
15.7% | -376.8%
Net Income
-437.5% | 118.3%
Free Cash Flow
-32.1%
Margin (TTM | estimate)
Gross
56.9%
EBITDA
1.2% | 8.3%
EBIT
-4.4%
Net
-64.7% | 2.6%
Free Cash Flow
4.7%
More
EPS
$-1.3
FCF per Share
$0.1
Short interest
3.2%
Employees
343
Rev per Employee
$270.0k
Show more

Is Harvard Bioscience, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Harvard Bioscience, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Harvard Bioscience, Inc. forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Harvard Bioscience, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Harvard Bioscience, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
89 89
12% 12%
100%
- Direct Costs 38 38
9% 9%
43%
50 50
14% 14%
57%
- Selling and Administrative Expenses 40 40
14% 14%
45%
- Research and Development Expense 9.41 9.41
18% 18%
11%
1.03 1.03
27% 27%
1%
- Depreciation and Amortization 4.91 4.91
9% 9%
6%
EBIT (Operating Income) EBIT -3.88 -3.88
16% 16%
-4%
Net Profit -57 -57
438% 438%
-65%

In millions USD.

Don't miss a Thing! We will send you all news about Harvard Bioscience, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Harvard Bioscience, Inc. Stock News

Neutral
Seeking Alpha
13 days ago
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q2 2025 Earnings Conference Call August 11, 2025 8:00 AM ET Company Participants John Duke - President, CEO & Director Mark T. Frost - Interim CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Bruce David Jackson - The Benchmark Company, LLC, Research Division Paul Richard Knight - KeyBanc Capital Mark...
Neutral
GlobeNewsWire
13 days ago
Reports Q2 2025 Revenues of $20.5M, Gross Margin of 56.4%, and Positive Cash Provided by Operations Third Quarter 2025 Guidance Reflects Improved Operations and Strong Financial Discipline New Credit Amendment Signed, Extending Refinance Deadline to December 5th HOLLISTON, Mass., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial ...
Neutral
GlobeNewsWire
20 days ago
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and will hold a conference call to discuss the results at 8:00 a.m.
More Harvard Bioscience, Inc. News

Company Profile

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Head office United States
CEO James Green
Employees 343
Founded 1901
Website www.harvardbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today